Christa Nath

11PUBLICATIONS
49CO-AUTHORS
PharmacogenomicsInfant and child healthHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 19, 2026
Physiologically Based Pharmacokinetic Virtual Twin Approach for Fludarabine Dosing in Pediatric Hematopoietic Stem Cell Transplantation.

Mourad Mseddi, Christa Nath, Khalil Ben Hassine

|Aug 19, 2025
PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia Treated within the AIEOP-BFM ALL 2009 Trial: Population Pharmacokinetics and Drug Exposure.

Gudrun Würthwein, Christian Siebel, Claudia Lanvers-Kaminsky

|Sep 19, 2024
The impact of age and renal function on the pharmacokinetics and protein binding characteristics of fludarabine in paediatric and adult patients undergoing allogeneic haematopoietic stem cell transplantation conditioning.

Christa E Nath, Sebastian P A Rosser, Kiran K Nath

|Jul 29, 2024
Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity.

Tim Bognàr, Moises Garcia-Rosa, Arief Lalmohamed

|Nov 12, 2022
Evaluation of treosulfan cumulative exposure in paediatric patients through population pharmacokinetics and dosing simulations.

Sebastian P A Rosser, Samiuela Lee, Shruti Kohli

|Oct 07, 2022
Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma.

Christa Ellen Nath, Andrew Grigg, Sebastian P A Rosser

Pageof 2

Frequent Collaborators

3 joint publications

Sebastian P A Rosser

2 joint publications

Peter J Shaw

2 joint publications

Chakradhara Rao S Uppugunduri

2 joint publications

Carmelo Rizzari